fbpx
Product quality

Product quality

ISO 13485 Certified
Patented Innovations
+2 Million Patients treated
CE certified

Patient safety

Patient safety

GMP Manufacturing
Class IIb & Class III Medical Devices
Non Pyrogenic – Sterile

A-PRP Efficacy

A-PRP Efficacy

Dedicated Kits for specific preparations
+ 200 published studies

More benefits for patients

Benefits of PRP therapy
for your patients.

Sportsman's injuries

Sportsman's injuries

Read the clinical evidence about treatment of tendinopathies and other musculoskeletal disorders.

Read more
Live better with confidence

Live better with confidence

View the clinical evidence for treatment of scars.

Read more
Improve the quality of life

Improve the quality of life

Read the clinical evidence about treatment of knee osteoarthritis.

Read more

Our products

Filter by
RegenKit® THT
RegenKit® ATS
RegenKit® BCT

RegenPRP standardized performance

a

Our Technology

The Regen Lab technology is based on the use of a thixotropic gel to separate the blood components. This process is protected by many patents (US8529957, EP2073862, US2014010857). Thixotropy is a physical property of some gels. The gel acts as a mechanical separator of the blood components.

Read More
a

Quality Products

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance. Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

Read More

Our News

Categorized as Blog

PRP – Rational/Indication Does current clinical evidence support the use of PRP for knee OA For which degrees of knee OA is PRP best indicated? Can PRP be used in severe knee OA (KL4)? Is PRP indicated for the treatment of Patellofemoral OA (PFOA)? Are there specific contraindications for the use of PRP for knee… Continue reading Home

Read more...

Categorized as Blog

In April 2022, following the annual ESSKA congress, a group of experts published an important document stating their recommendations on the use of PRP in the management of knee osteoarthritis. This is a consensus paper which was obtained after more than 2 years of deliberations on the subject, answering 28 specific questions for which an… Continue reading Home

Read more...

Categorized as Latest Global News and Events

Friday 3rd to Sunday 5th June @ Paris Session program coming soon ! More informations

Read more...
about balloons

About us

Since 2003, RegenLab® has been committed to the development of a unique expertise in the design and manufacturing of high-quality medical devices, intended for the preparation of cellular therapies and autologous platelet-rich plasma (PRP) from the patient’s own blood. Bringing these technologies to the United States in 2013, RegenLab® USA offers Regen® A-PRP® and Autologous Thrombin Serum with a focus on product quality, patient safety, and preparation efficiency. Now in 2022, RegenLab is proud to be manufactured in the USA. As we look to the future, we are committed to guiding new standards for emerging categories within the field of regenerative medicine.

History: Founded in Switzerland in 2003, Our patient-centered technology has led to over one million treatments provided worldwide using RegenLab® products. In 2017, a new Good Manufacturing Practice (GMP) facility was completed in Mont-sur-Lausanne, Switzerland (canton of Vaud-needed?) allowing RegenLab® to increase access to autologous cellular therapies around the world.

Read More

Our offices and subsidiaries around the world

  • New York (USA)
  • Montréal (Canada)
  • Venice (Italy)
  • Munich (Germany)
  • Paris (France)
  • Dubai (U.A.E.)
  • Beijing (China)
  • and Istanbul (Turkey)
map map balloons

Partners and affiliations

partners
partners
partners
partners
partners
partners
partners
partners

Contact Regenlab

Now is the time to change your patient’s life. Browse ressources and
get connected to treatment that is right for them.

For more information on our products, please contact us by clicking on the button below:

address

Our Regional offices are
located in

  • New York (USA)
  • Montréal (Canada)
  • Venice (Italy)
  • Munich (Germany)
  • Paris (France)
  • Dubai (U.A.E.)
  • Beijing (China)
  • Istanbul (Turkey)